1. Home
  2. BZUN vs NERV Comparison

BZUN vs NERV Comparison

Compare BZUN & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

SELL

Current Price

$3.70

Market Cap

164.5M

ML Signal

SELL

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$2.38

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
NERV
Founded
2007
2007
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
166.4M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
BZUN
NERV
Price
$3.70
$2.38
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$4.58
★ $10.33
AVG Volume (30 Days)
★ 300.9K
135.5K
Earning Date
11-24-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
$8.08
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$2.31
52 Week High
$3.82
$12.46

Technical Indicators

Market Signals
Indicator
BZUN
NERV
Relative Strength Index (RSI) 70.36 22.50
Support Level $2.74 N/A
Resistance Level N/A $5.69
Average True Range (ATR) 0.20 0.25
MACD 0.04 -0.07
Stochastic Oscillator 83.17 6.25

Price Performance

Historical Comparison
BZUN
NERV

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: